H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $19.62 | |||
| Open | $1.50 | 52 Week Low | $7.65 | |||
| Day High | $1.52 | P/E | N/A | |||
| Day Low | $1.46 | EPS | $-0.22 | |||
| Volume | 545,378 | |||||
